Clinical Trials Logo

HPV-Related Malignancy clinical trials

View clinical trials related to HPV-Related Malignancy.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05061940 Terminated - Clinical trials for Head and Neck Cancer

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Start date: May 5, 2021
Phase:
Study type: Observational

The purpose of this study is to obtain archived tumor tissue or pre-existing antigen expression data from patients with Head and Neck, Cervical, Melanoma and Non-Small Cell Lung Cancers to assess antigen expression and patient suitability for a Repertoire Immune Medicines Treatment Protocol.